Trial intelligence / Profile preview

Effects of Erythropoietin on Platelet Function in Acute MI

NCT00367991Phase 2Completed

Sponsor
Yale University
Start
Nov 2006
Primary completion
Mar 2008
Modality
Biologic, rProtein (Recombinant Protein)
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in myocardial infarction (MI) comparing rHuEpo with Placebo (2 arms). Primary endpoints: Bleeding Time and Platelet Function Assay Closure Time. Started Nov 2006; status: completed.

02

Drugs

epoetin alfa
03

Conditions

myocardial infarction (MI)

Beyond the preview

Go deeper on NCT00367991.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00367991.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call